Order these courses at a special price and receive 25 ASRT approved credits. You will receive the following courses: Cystic Fibrosis, Parkinson's Disease, Thrombosis & Pandemics.
Cystic fibrosis afflicts approximately 30,000 Americans. The average age of survival has been steadily increasing, but not quickly enough: a child born with cystic fibrosis today can only expect to live 35 to 40 years. In this valuable new addition to the Your Personal Health series, Dr. Wayne Kepron offers a comprehensive look at the disease that afflicts so many young people. Topics include: Symptoms of cystic fibrosis,Making a diagnosis,Complications of the disease,Treatments (including lung transplants),Techniques and precautions in lung care,Transition into adulthood,Prospects for gene therapy,and end-of-life issues. Using diagrams, charts and case studies, Cystic Fibrosis is designed for patients, their families, and caregivers. It is both a quick reference guide and a tool for in-depth study.
This practical guide covers current approaches and new developments in the diagnosis, treatment, and management of both early PD and advanced PD. It also addresses the role of imaging studies in the diagnosis, differential diagnosis, and monitoring of the progression of PD. In addition to providing up-to-date information on pharmacological therapies, the book also describes the surgical management of the disease, as well as non-pharmacological treatment options. It also covers new data on the genetic causes of PD.
Thrombosis is the formation of a solid blood clot in an arterial or venous vessel where it can interfere with normal blood flow. About 1 in 20 suffers from vein clots or lung clots at some point, and about half of those suffering from thrombosis have other illnesses such as cancer or develop the clot while recovering from surgery or a serious accident. While most episodes of blood clotting are not dangerous, some can be serious and even fatal.
This course explains the causes of pandemics, how they can be counteracted with vaccines and drugs, and how we can better prepare for them in the future.